Paid Clinical Trials in La Crosse, WI
As of July 2026, 96 paid clinical trials are recruiting in La Crosse, Wisconsin. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
La Crosse offers studies at sites including Gundersen Lutheran Medical Center for conditions such as Stage IV Lung Cancer AJCC v8, Acute Myeloid Leukemia, Stage IIIB Lung Cancer AJCC v8, Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in La Crosse
Filter results
0 clinical trials
·Clear filters·Top Research Study Locations in La Crosse
Researchers run research studies in La Crosse, WI at 19 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Gundersen Lutheran Medical Center | Stage IV Lung Cancer AJCC v8, Acute Myeloid Leukemia, Stage IIIB Lung Cancer AJCC v8 | 64 |
| Mayo Clinic Health System-Franciscan Healthcare | Stage III Prostate Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 11 |
| Gundersen Health System | Geographic Atrophy Secondary to Age-related Macular Degeneration, Amblyopia, Arthroplasties, Knee Replacement | 7 |
| Gundersen Health System, Merz Investigational | Chronic Migraine, Episodic Migraine | 2 |
| Gundersen Health System - La Crosse Medical Center | AMD, CNV, Wet Age-related Macular Degeneration | 2 |
| Gundersen | Extensive Stage Lung Small Cell Cancer | 1 |
| Gundersen Health | Coronary Artery Disease, Ischemic Heart Disease | 1 |
| Gundersen Lutheran | Coronary Artery Disease | 1 |
| Gundersen Lutheran Medical Foundation | Epidermal Growth Factor Receptor Gene Mutation, Non Small Cell Lung Cancer, Stage III Lung Cancer | 1 |
| Gundersen Lutheran Medical Foundation (Data Collection Only) | Hepatectomy | 1 |
| Gunderson Health | Breast Cancer, Early Stage Breast Cancer, HER2 + Breast Cancer | 1 |
| Gunderson Health System | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 1 |
| La Crosse Mayo Clinic | Alzheimer Disease and Related Dementias (ADRD), Hearing Loss, Mild Cognitive Impairment | 1 |
| Mayo Clinic Health System - La Crosse | Breast Cancer | 1 |
| Mayo Clinic Health System - Southwest Wisconsin | Adnexal Mass, Atypical Endometrial Hyperplasia, Cervical Cancer | 1 |
| Mayo Clinic Health System SW Wisconsin | Cardiovascular Diseases, Cognitive Impairment, Mild, Dementia | 1 |
| Mayo Clinic Health System- La Crosse | Lumbar Spinal Stenosis | 1 |
| Mayo Clinic Health System-La Crosse | Community-acquired Pneumonia | 1 |
| University of Wisconsin La Crosse | Inflammation, Peripheral Arterial Disease, Walking, Difficulty | 1 |
Active & Upcoming Studies in La Crosse (2026)
Recruiting trials in La Crosse grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (71 active studies)
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · Phase 2 · National Cancer Institute (NCI)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
Eye & vision (4 active studies)
- An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA) · Phase 1, Phase 2 · Complement Therapeutics
- A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA) · Complement Therapeutics
Neurology & pain (3 active studies)
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine · Phase 3 · Merz Therapeutics GmbH
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine · Phase 3 · Merz Therapeutics GmbH
Mental health & behavior (2 active studies)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
- Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program · Phase 3 · Alliance for Clinical Trials in Oncology
Cardiovascular (2 active studies)
- Prevail Global Study · Medtronic Vascular
- Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting · Philips Clinical & Medical Affairs Global
Common conditions studied in La Crosse
- Stage IV Lung Cancer AJCC v8 (6 active studies)
- Acute Myeloid Leukemia (5 active studies)
- Stage IIIB Lung Cancer AJCC v8 (5 active studies)
- Breast Cancer (4 active studies)
- Lung Non-Small Cell Carcinoma (4 active studies)
- Recurrent Lung Non-Small Cell Carcinoma (4 active studies)
Leading research sponsors in La Crosse
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- Mayo Clinic
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in La Crosse?
There are approximately 96 recruiting clinical trials in La Crosse, Wisconsin listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in La Crosse pay participants?
Most recruiting trials in La Crosse compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in La Crosse?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in La Crosse?
The most common conditions under active study in La Crosse include Stage IV Lung Cancer AJCC v8 (6), Acute Myeloid Leukemia (5), Stage IIIB Lung Cancer AJCC v8 (5), Breast Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in La Crosse?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in La Crosse on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in La Crosse?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in La Crosse?
Recruiting research sites in La Crosse include Gundersen Lutheran Medical Center, Mayo Clinic Health System-Franciscan Healthcare, Gundersen Health System, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in La Crosse right now?
The largest active categories in La Crosse are Cancer & tumors (71), Eye & vision (4), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.